Recombinant Human SNAP25 Protein，His

SNAP25, or Synaptosomal-Associated Protein 25 kDa, is a crucial membrane protein that plays a significant role in synaptic transmission. It is a key component of the SNARE (Soluble N-ethylmaleimide-sensitive factor attachment protein receptor) complex, which facilitates the fusion of synaptic vesicles with the presynaptic membrane, enabling neurotransmitter release. Research on SNAP25 has garnered attention due to its involvement in various neurological disorders, including schizophrenia, autism, and attention deficit hyperactivity disorder (ADHD). Its function is modulated by post-translational modifications, such as phosphorylation and palmitoylation, which can influence synaptic plasticity and overall neuronal communication. Moreover, SNAP25 has been implicated in toxin-mediated processes, such as the action of botulinum neurotoxins, which cleave SNAP25 and disrupt neurotransmission, leading to paralysis. Understanding the structural and functional dynamics of recombinant SNAP25 is therefore essential for elucidating its role in both healthy and pathological states. Recent advances in protein engineering and crystallography have facilitated the characterization of SNAP25, providing insights into its interactions with other SNARE proteins and cellular machinery. This research not only enhances our understanding of fundamental neurobiology but also holds potential for therapeutic interventions aimed at modulating neurotransmitter release in various psychiatric and neurological conditions. Thus, the study of recombinant SNAP25 continues to be a vital area within neuroscience, bridging molecular mechanisms and potential clinical applications.